These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 2352328

  • 1. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.
    Wang F, Tsang SF, Kurilla MG, Cohen JI, Kieff E.
    J Virol; 1990 Jul; 64(7):3407-16. PubMed ID: 2352328
    [Abstract] [Full Text] [Related]

  • 2. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E.
    J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression.
    Tsang SF, Wang F, Izumi KM, Kieff E.
    J Virol; 1991 Dec; 65(12):6765-71. PubMed ID: 1658373
    [Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
    Allday MJ, Crawford DH, Thomas JA.
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
    [Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.
    Lin J, Johannsen E, Robertson E, Kieff E.
    J Virol; 2002 Jan; 76(1):232-42. PubMed ID: 11739688
    [Abstract] [Full Text] [Related]

  • 8. The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines.
    Nakagomi H, Dolcetti R, Bejarano MT, Pisa P, Kiessling R, Masucci MG.
    Int J Cancer; 1994 Apr 15; 57(2):240-4. PubMed ID: 8157362
    [Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element.
    Wang F, Kikutani H, Tsang SF, Kishimoto T, Kieff E.
    J Virol; 1991 Aug 15; 65(8):4101-6. PubMed ID: 1649318
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
    Cohen JI, Wang F, Mannick J, Kieff E.
    Proc Natl Acad Sci U S A; 1989 Dec 15; 86(23):9558-62. PubMed ID: 2556717
    [Abstract] [Full Text] [Related]

  • 11. Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection.
    Contreras-Salazar B, Ehlin-Henriksson B, Klein G, Masucci MG.
    J Virol; 1990 Nov 15; 64(11):5441-7. PubMed ID: 2170681
    [Abstract] [Full Text] [Related]

  • 12. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
    Sjöblom A, Nerstedt A, Jansson A, Rymo L.
    J Gen Virol; 1995 Nov 15; 76 ( Pt 11)():2669-78. PubMed ID: 7595374
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain.
    Nitsche F, Bell A, Rickinson A.
    J Virol; 1997 Sep 15; 71(9):6619-28. PubMed ID: 9261384
    [Abstract] [Full Text] [Related]

  • 14. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Wang F, Gregory CD, Rowe M, Rickinson AB, Wang D, Birkenbach M, Kikutani H, Kishimoto T, Kieff E.
    Proc Natl Acad Sci U S A; 1987 May 15; 84(10):3452-6. PubMed ID: 3033649
    [Abstract] [Full Text] [Related]

  • 15. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation.
    Mannick JB, Cohen JI, Birkenbach M, Marchini A, Kieff E.
    J Virol; 1991 Dec 15; 65(12):6826-37. PubMed ID: 1658376
    [Abstract] [Full Text] [Related]

  • 16. Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.
    Harada S, Yalamanchili R, Kieff E.
    J Virol; 1998 Dec 15; 72(12):9948-54. PubMed ID: 9811732
    [Abstract] [Full Text] [Related]

  • 17. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
    Doyle MG, Crawford DH.
    Intervirology; 1994 Dec 15; 37(5):236-44. PubMed ID: 7698878
    [Abstract] [Full Text] [Related]

  • 18. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis.
    Peng M, Lundgren E.
    Oncogene; 1992 Sep 15; 7(9):1775-82. PubMed ID: 1354347
    [Abstract] [Full Text] [Related]

  • 19. B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: studies with somatic cell hybrids.
    Contreras-Brodin BA, Anvret M, Imreh S, Altiok E, Klein G, Masucci MG.
    J Gen Virol; 1991 Dec 15; 72 ( Pt 12)():3025-33. PubMed ID: 1662694
    [Abstract] [Full Text] [Related]

  • 20. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines.
    Kriauciunas KM, Goldstein BJ, Lipes MA, Kahn CR.
    J Cell Physiol; 1993 Mar 15; 154(3):486-95. PubMed ID: 8382208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.